Exelixis (EXEL) Restructuring Costs (2010 - 2026)

Exelixis (EXEL) posted quarterly Restructuring Costs of $694000.0 for Q1 2026, up 136.05% year-over-year from $294000.0 in Q1 2025, and down 96.5% quarter-over-quarter from $19.8 million in Q4 2025.

Exelixis (EXEL) Restructuring Costs (2010 - 2026) Analysis & Trends

Exelixis' Restructuring Costs history runs 11 years deep, the most recent figure standing at $694000.0 for Q1 2026.

  • In Q1 2026, Restructuring Costs rose 136.05% year-over-year to $694000.0; the TTM figure through Jan 2026 stood at $20.5 million (down 39.14% YoY), while the FY2026 annual figure was $20.5 million, down 39.14% from the prior year.
  • Restructuring Costs for Q1 2026 stood at $694000.0, down from $19.8 million in the prior quarter.
  • The five-year high for Restructuring Costs was $32.8 million in Q1 2024, with the low at $96000.0 in Q3 2024.
  • The 3-year median for Restructuring Costs is $584500.0 (2024), against an average of $9.0 million.
  • The sharpest annual moves came in 2025 and 2026: Restructuring Costs jumped 20541.67% in 2025, then soared 136.05% in 2026.
  • Exelixis' Restructuring Costs stood at $96000.0 in 2024, then surged by 20541.67% to $19.8 million in 2025, then tumbled by 96.5% to $694000.0 in 2026.
  • Business Quant data shows EXEL's Restructuring Costs at $694000.0 in Q1 2026, $19.8 million in Q4 2025, and $294000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Exelixis 12.75 Bn 11.91 Bn 608.03 Mn

Historic Data

Download Data
DateValue
Jan 2, 2026 694,000.00
Oct 3, 2025 19.82 Mn
Jan 3, 2025 294,000.00
Sep 27, 2024 96,000.00
Jun 28, 2024 475,000.00
Mar 29, 2024 32.84 Mn
Jun 30, 2017 -60,000.00
Mar 31, 2017 28,000.00
Dec 30, 2016 -228,000.00
Sep 30, 2016 -244,000.00
Jun 30, 2016 1.02 Mn
Mar 31, 2016 94,000.00
Sep 30, 2015 282,000.00
Jun 30, 2015 1.29 Mn
Mar 31, 2015 -431,000.00
Dec 31, 2014 3.46 Mn
Sep 30, 2014 3.76 Mn
Jun 30, 2014 331,000.00
Mar 31, 2014 46,000.00
Dec 31, 2013 366,000.00